Article
Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
The Prostate - 1 Sept 2008
Stevens Victoria L, Rodriguez Carmen, Talbot Jeffrey T, Pavluck Alexandre L, Thun Michael J, Calle Eugenia E
Abstract excerpt
BACKGROUND: The HDL-associated enzyme paraoxonase 1 acts to decrease oxidative stress, which is thought to contribute to cancer development. PON1, which encodes paraoxonase 1, has two common, nonsynonymous SNPs that alter the activity of this enzyme and may influence cancer risk. METHODS: We investigated the association the nonsynonymous SNPs, Q192R and L55M, with prostate cancer risk in a nested case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
